INSIGHT MM & the benefits of real-world evidence
Jim Omel discusses his participation in the INSIGHT MM & the benefits of real-world evidence with patients participating in trials in multiple myeloma.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Jim Omel discusses his participation in the INSIGHT MM & the benefits of real-world evidence with patients participating in trials in multiple myeloma.
- Key Point: Jim has been living with multiple myeloma since 1997 and is an active member of the INSIGHT MM steering committee, as well as one of the lead authors of the study.
- Key Point: When his disease relapsed in 2000 following a stem cell transplant, Jim retired from his medical practice to begin a new career as a patient advocate.
- Key Point: An unofficial “myeloma expert,” Jim uses his medical knowledge to help people with multiple myeloma via a vast network of organizations, including the National Cancer Instit…
- Key Point: Food, and Drug Administration’s (FDA) Myeloma Steering Committee and the Alliance Cooperative Group, among others.
Jim has been living with multiple myeloma since 1997 and is an active member of the INSIGHT MM steering committee, as well as one of the lead authors of the study. When his disease relapsed in 2000 following a stem cell transplant, Jim retired from his medical practice to begin a new career as a patient advocate. An unofficial “myeloma expert,” Jim uses his medical knowledge to help people with multiple myeloma via a vast network of organizations, including the National Cancer Institute, the Central Nebraska Myeloma Support Group, the U.S. Food, and Drug Administration’s (FDA) Myeloma Steering Committee and the Alliance Cooperative Group, among others.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


